[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Damora Therapeutics Inc (DMRA)

Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Damora Therapeutics Inc 221 Crescent Street Building 23 Suite 105 Boston MA 02453 DNK

www.damoratx.com Employees: 7 P: 781-281-9020

Sector:

Medical

Description:

Galecto Inc. is a clinical stage biotechnology company with advanced programs in fibrosis and cancer centered on galectin-3 and LOXL2. The Company's pipeline includes an inhaled galectin-3 modulator currently in Phase 2b for the potential treatment of idiopathic pulmonary fibrosis. Galecto Inc. is headquarters in Copenhagen, Denmark.

Key Statistics

Overview:

Market Capitalization, $K 1,907,528
Enterprise Value, $K 2,066,158
Shares Outstanding, K 61,553
Float, K 61,307
% Float 99.60%
Short Interest, K 3,568
Short Float 5.80%
Days to Cover 2.63
Short Volume Ratio 0.53
% of Insider Shareholders 0.40%
% of Institutional Shareholders 14.20%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -209,840 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -27,780 K
EBIT, $ -239,090 K
EBITDA, $ -239,070 K

Growth:

1-Year Return 770.97%
3-Year Return -46.41%
5-Year Return -71.86%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.91%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.62 on 05/12/26
Next Earnings Date 08/04/26 [--]
Earnings Per Share ttm -5.58
EPS Growth vs. Prev Year 67.71%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/30/24

DMRA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -428.30%
Return-on-Assets % -114.62%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.45
Book Value/Share 8.48
Interest Coverage -20.65
60-Month Beta 1.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.